The Effect of COVID-19 on Diabetes Mellitus

N/AUnknownNCT04592055

Uşak University500 enrolled

Overview

The study aimed to evaluate the effect of SARS-COV-2 infection on metabolic status in patients with diabetes mellitus. Patients' HbA1c levels before and after SARS-COV-2 infection will be evaluated.

In this time pediods, all patients with RT-PCR positive for SARS-COV-2 will be analysed for the presence of diabetes mellitus. Previous HbA1c levels will be obtained from hospital records. In these patients, previous A1c levels and A1c levels 3 months after the SARS-COV-2 infection will be compared.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Diabetes Mellitus Covid19

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: \- All hospitalised diabetic patients with RT-PCR- positive for SARS-COV-2 will be enrolled. Exclusion Criteria: \- The absence of diabetes mellitus RT-PCR- negative for SARS-COV-2 Non-hospitalised patients

Locations (1)

Usak University Training and Research Hospital

Uşak, Turkey (Türkiye)

RECRUITING

Outcomes

Primary Outcomes

A1c

the change in A1c levels

Time frame: 6 months (3 months before and after COVID-19

Central Contacts

Cevdet Duran

CONTACT

02762212121 drcduran@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.